TESTOSTERONE CYPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Testosterone Cypionate patents expire, and what generic alternatives are available?
Testosterone Cypionate is a drug marketed by Am Regent, Cipla, Eugia Pharma, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, Wilshire Pharms Inc, Xiromed, and Slayback Pharma Llc. and is included in sixteen NDAs. There are two patents protecting this drug.
The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
DrugPatentWatch® Generic Entry Outlook for Testosterone Cypionate
Indicators of Generic Entry
Summary for TESTOSTERONE CYPIONATE
US Patents: | 2 |
Applicants: | 14 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 26 |
Patent Applications: | 3,313 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TESTOSTERONE CYPIONATE |
DailyMed Link: | TESTOSTERONE CYPIONATE at DailyMed |
Recent Clinical Trials for TESTOSTERONE CYPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Sao Paulo | N/A |
Fundação de Amparo à Pesquisa do Estado de São Paulo | N/A |
Clarus Therapeutics | Phase 2 |
Pharmacology for TESTOSTERONE CYPIONATE
Drug Class | Androgen |
Mechanism of Action | Androgen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for TESTOSTERONE CYPIONATE
US Patents and Regulatory Information for TESTOSTERONE CYPIONATE
TESTOSTERONE CYPIONATE is protected by two US patents.
Patents protecting TESTOSTERONE CYPIONATE
Pharmaceutical compositions of testosterone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Am Regent | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 207742-001 | Jun 16, 2017 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Pharms Inc | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 086030-001 | Approved Prior to Jan 1, 1982 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE | estradiol cypionate; testosterone cypionate | INJECTABLE;INJECTION | 085603-001 | Mar 13, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 090387-002 | Jul 15, 2010 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |